Aileron Therapeutics, Inc. (ALRN) News Headlines

▮ More

Date

Headline

8/11/2020 1:57:59 AM CPRX Plunges As MuSK-MG Trial Flops, MESO Awaits FDA Panel Review, EQ Soars After-hrs

8/4/2020 3:31:42 AM ALRN To Report Data In Q4, IMUC Hits New High, VYGR Pulls Out Of ABBV Deal, VNDA To Face FDA In Dec.

6/1/2020 7:20:26 AM Aileron Therapeutics Reports Positive Interim Data From Phase 1b/2 Clinical Trial Of ALRN-6924

12/18/2019 8:44:59 AM Aileron Therapeutics Promotes Richard Wanstall To CFO And Treasurer

9/9/2019 8:19:11 AM Aileron Therapeutics CFO Don Dougherty To Leave

6/24/2019 8:11:07 AM Aileron Therapeutics Elects William McKee And Josef Von Rickenbach To Board

3/12/2019 9:15:40 PM 8 Top Gainers In Healthcare Sector (ALRN, NDRA, DOVA...)

2/26/2019 9:16:34 PM 6 Top Gainers In Healthcare Sector (SMMT, HTBX, NTGN...)

2/12/2019 9:09:45 PM 5 Top Gainers In Healthcare Sector (CASM, VKTX, ADMA...)

2/4/2019 8:41:41 PM 7 Top Gainers In Healthcare Sector (ALRN, APHA, INSY...)

1/16/2019 7:57:36 PM 6 Top Gainers In Healthcare Sector (BIOC, ALRN, VCNX...)

12/4/2018 9:17:27 AM Aileron Presents Interim ALRN-6924 Data From PTCL, MDS, And AML Clinical Trials

11/27/2018 8:11:12 AM Aileron Enters Clinical Trial Collaboration With Pfizer To Evaluate ALRN-6924 Plus IBRANCE In MDM2-Amplified Cancers

11/13/2018 8:18:23 PM ALRN Gearing Up For ASH, RUBY Shines, UMRX, ZIOP On Watch

11/5/2018 4:11:03 PM Aileron Therapeutics Appoints Vojislav Vukovic As Chief Medical Officer

10/16/2018 8:26:15 PM KRYS Up 53% In 2 Days, SLS To Report Phase 2 Data Next Week, OMED On Watch

9/10/2018 10:55:21 PM ACOR Loses Ampyra Patent Appeal, XBIT Awaits Data, AYTU Touches New Low

9/6/2018 11:30:31 PM IOVA Slumps, MSON On Watch, ALRN To Report Data In Q4

9/6/2018 9:04:34 AM Aileron Therapeutics Appoints Manuel Aivado As President And CEO

9/4/2018 9:20:57 PM MNKD Takes Giant Leap, REPH On Watch, ALRN To Report Study Data In Q4